Skip to main content

Life Sciences

By Emily Olsen | 01:19 pm | April 21, 2022
Reify said it will use the investment to focus its tools on increased diversity in clinical trials.
By Emily Olsen | 02:52 pm | April 20, 2022
Also: Employer-focused mental health startup Spring Health makes two new hires, and Carrot Fertility adds to its medical team.
By Emily Olsen | 03:22 pm | April 19, 2022
Also: RPM company Blue Spark Technologies brought in $40 million in IP-backed debt financing, and Click Therapeutics secured a $15 million loan.
By Emily Olsen | 12:45 pm | April 19, 2022
This marks THREAD's third recent acquisition, including the inVibe deal announced early this year and the Modus Outcomes purchase from November.
By Laura Lovett | 12:43 pm | April 18, 2022
A new study in The Lancet found that a deep-learning algorithm was able to detect vision-threatening retinopathy with 94.7% accuracy. 
By Laura Lovett | 04:21 pm | April 12, 2022
The study did not find find a significant difference in depression symptoms between the intervention and control group.  
By Adam Ang | 12:45 am | April 07, 2022
It initially offers medicines and other healthcare products and services from over 500 independent sellers.
By Laura Lovett | 03:57 pm | April 06, 2022
A new study published in the Lancet found that patients using VR therapy had a significant reduction in agoraphobic avoidance and distress compared to participants receiving usual care.
By Emily Olsen | 12:58 pm | April 06, 2022
The company said it will use the financing to expand in Europe and the U.S., and develop new digital therapeutics with its pharma partners.
By Emily Olsen | 02:04 pm | April 05, 2022
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.